2025-05-04 - Analysis Report
## Rocket Lab USA Inc (RKLB) Stock Review

**0) Summary of Key Figures:**

* **Cumulative Return (RKLB):** 182.95%
* **Cumulative Return (VOO):** 22.31%
* **Return Difference (RKLB vs VOO):** 160.6%
* **Relative Divergence (RKLB vs VOO):** 90.3% (Indicates RKLB significantly outperformed VOO historically, but within the context of its historical volatility)
* **Current Price:** $22.99
* **5-Day Moving Average:** $22.39
* **20-Day Moving Average:** $20.25
* **60-Day Moving Average:** $20.98
* **RSI:** 65.33 (Slightly overbought)
* **PPO:** 1.77 (Positive, suggesting bullish momentum)
* **MRI:** 0.3776 (Medium Risk)
* **Expected Return (Long-term):** -4.6% (relative to S&P 500)


**1) Company Overview and Performance Comparison:**

Rocket Lab USA Inc. is a space launch and satellite company.  Its cumulative return significantly outperforms the S&P 500 (VOO) by 160.6 percentage points.  However, the relative divergence of 90.3% highlights the substantial variability in its historical performance relative to the S&P 500.  The alpha consistently hovers around -0.1, suggesting underperformance relative to market benchmarks adjusted for risk (beta), although this fluctuates across the periods analysed and recent performance is much more positive. Beta values indicate higher volatility than the market. Capitalization has grown significantly.


**Alpha, Beta Analysis:**

| Year       | CAGR     | MDD     | Alpha  | Beta   | Cap(B) |
|------------|----------|---------|--------|--------|--------|
| 2020-2022  | -39.0%   | 70.8%   | -0.1   | 1.7    |       |
| 2021-2023  | 0.0%     | 71.5%   | -0.1   | 2.5    |       |
| 2022-2024  | 189.0%   | 74.7%   | -0.0   | 11.8   |       |
| 2023-2025  | 202.0%   | 74.7%   | -0.1   | 10.6   |       |


**2) Recent Price Movement:**

The recent price shows a 3.93% increase from the previous close, indicating a recent upswing.  The price is currently above both the 5-day and 20-day moving averages, suggesting short-term upward momentum. However, it is slightly below the 60-day moving average, indicating some potential for correction or consolidation.


**3) Technical Indicators and Expected Return:**

The RSI of 65.33 suggests the stock is slightly overbought, implying potential for a short-term pullback.  The positive PPO value of 1.77 supports the bullish momentum indicated by the price movement. The recent positive relative divergence (0.6) indicates a short-term upward trend. The Market Risk Indicator (MRI) of 0.3776 falls into the medium-risk category. The expected return of -4.6% over the long term (2+ years) suggests potential underperformance compared to the S&P 500, though this is contingent on multiple factors, and this should be considered alongside the companyâ€™s recent growth performance. The sharp price increase (3.93%) reflects this positive momentum and may indicate that the market is factoring in future positive growth prospects.


**4) Recent Earnings Analysis:**

| Date       | EPS      | Revenue       |
|------------|----------|---------------|
| 2024-11-12 | -0.1     | $0.10 B       |
| 2024-08-08 | -0.08    | $0.11 B       |
| 2024-05-06 | -0.09    | $0.09 B       |
| 2023-11-08 | -0.08    | $0.07 B       |
| 2024-11-12 | -0.08    | $0.07 B       | *(Note: This appears to be a duplicate entry)*

Revenue is growing steadily, although the company remains unprofitable.  There's a need for further analysis to understand the reasons behind the consistent negative EPS.


**5) Financial Information:**

**Revenue and Profitability:**

| Quarter     | Revenue    | Profit Margin |
|-------------|------------|---------------|
| 2024-12-31  | $0.13B     | 27.81%        |
| 2024-09-30  | $0.10B     | 26.71%        |
| 2024-06-30  | $0.11B     | 25.56%        |
| 2024-03-31  | $0.09B     | 26.06%        |
| 2023-12-31  | $0.06B     | 25.82%        |

Revenue shows a clear upward trend. Profit margins remain relatively stable and healthy.

**Capital and Profitability:**

| Quarter     | Equity     | ROE          |
|-------------|------------|---------------|
| 2024-12-31  | $0.38B     | -13.69%       |
| 2024-09-30  | $0.42B     | -12.37%       |
| 2024-06-30  | $0.46B     | -9.15%        |
| 2024-03-31  | $0.48B     | -9.24%        |
| 2023-12-31  | $0.55B     | -9.11%        |

Equity is decreasing, while ROE remains negative, indicating the company is not yet generating profits from its equity. This is a key area of concern.


**6) Overall Analysis:**

RKLB shows strong historical growth significantly exceeding the S&P 500.  However, this growth has been volatile, and the company is currently unprofitable despite increasing revenue.  Technical indicators suggest short-term upward momentum, but the RSI hints at potential overbought conditions.  Long-term prospects are uncertain, given the negative projected return relative to the S&P 500 and negative ROE.  Further investigation into the reasons for consistent negative EPS and the decreasing equity despite revenue growth is crucial.  Investors should carefully consider the high volatility and the company's profitability before making investment decisions.  The recent price jump warrants caution; is it sustainable or a temporary spike?  A deeper dive into the company's operational efficiency, future growth plans, and competitive landscape is essential for a thorough assessment.
